6-K XBRL

FORM 6-K

Company: NYMOX PHARMACEUTICAL CORP
Filed: May 14, 2020
Period of Report: March 31, 2020
Accession Number: 0001640334-20-001197

View Document ↗ View on SEC.gov ↗